India’s medicine price regulator National Pharmaceutical Pricing Authority (NPPA) has asked all drug companies to reduce the prices of all medicines by 2.4 per cent to pass on the benefits of the recent excise duty cut to the consumer.
On December 7, the government had announced an across the board cut of 4 per cent on excise duties. The tax on medicine, which was earlier 8 per cent, had thus come down to 4 per cent.
In a press note, NPPA has asked the companies to comply with the reduction in excise duty and furnished a revised price list to the authority.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
